News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
3 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (232)
2 (101)
3 (1)
4 (13)
5 (26)
6 (344)
7 (346)
8 (264)
9 (107)
10 (31)
11 (18)
12 (255)
13 (267)
14 (212)
15 (206)
16 (111)
17 (4)
18 (5)
19 (157)
20 (226)
21 (187)
22 (190)
23 (79)
24 (1)
25 (3)
26 (175)
27 (201)
28 (178)
29 (232)
30 (88)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Drug Development
FDA Action Alert: Amylyx’s Moment of Truth and Dupixent Seeks another Nod
The FDA might only have two PDUFA dates on the calendar this week, but all eyes in the neurodegenerative disease community will be on the first one: Amylyx’s AMX0035 for ALS.
September 25, 2022
·
2 min read
·
Mark Terry
Policy
Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of Renal Diseases
Everest Medicines announced that the China National Medical Products Administration ‘s Center for Drug Evaluation has approved the Investigational New Drug application for a Phase 1b study of EVER001, a next-generation covalent reversible Bruton’s tyrosine kinase inhibitor, in development for the treatment of glomerular diseases.
September 25, 2022
·
4 min read
BioForest
Clearmind Announces Notice of Proposed Stock Consolidation - September 25, 2022
Clearmind Medicine Inc., announces that it will be consolidating all of the issued and outstanding common shares of the Company on the basis of one post consolidation Common Share for each thirty pre consolidation Common Shares.
September 25, 2022
·
4 min read
